Milestones

1. International leadership of the Hospital in the coordination of the European clinical guideline of recommendations for the management of chronic liver disease in patients with Fontan surgery (Fontan-associated Liver Disease) First author: Dr. Luis Téllez.
2. Guerrero A, Campo LD, Piscaglia F, Scheiner B, Han G, Violi F, Ferreira CN, Téllez L, Reiberger T, Basili S, Zamora J, Albillos A, Baveno Cooperation: an EASL C. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis. J Hepatol. 2023;79(1): 69 - 78. DOI:10.1016/j.jhep.2023.02.023. PMID: 36858157.
3. Assessing the carbon footprint of endoscopic procedures and actions to reduce it. Cunha JA, Roseira J, Cunha MF, Pellino G, Sampietro GM, Rodríguez de Santiago E. Towards a greener endoscopy: Considerations on the strategies to improve sustainability. Dig Liver Dis. 2023;55(4): 429 - 430. DOI:10.1016/j.dld.2022.12.017. PMID: 36682924.
4. Establishing the benefit of beta-blocker treatment to prevent hepatic decompensation in cirrhosis. Rowe IA, Villanueva C, Shearer JE, Torres F, Albillos A, Genescà J, Garcia JC, Tripathi D, Hayes PC, Bosch J, Abraldes JG, PREDESCI I. Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial. Hepatology. 2023;78(2): 530 - 539. DOI:10.1097/HEP.0000000000000342. PMID: 36897269.  
5. Health outcomes of esophageal mucosal ablation to treat GERD. Shimamura Y, Inoue H, Tanabe M, Ushikubo K, Yamamoto K, Kimoto Y, Nishikawa Y, Ando R, Sumi K, Navarro MJ, Teruel Sanchez C, Peñas B, Parejo S, Martínez A, Vazquez E, Onimaru M, Albillos A, Rodriguez de Santiago E. Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study. J Gastroenterol Hepatol. 2023;39(1): 149 - 156. DOI:10.1111/jgh.16370. PMID: 37787176